D3 Bio pockets $200m Series A
D3 Bio, a global biotechnology company, has raised $200 million in Series A financing.
D3 Bio, a global biotechnology company, has raised $200 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination